Pharming Group announces presentation of new leniolisib data at 2022 ASH Annual Meeting
Presentation to highlight data from the ongoing long-term open-label extension study of leniolisib, a PI3Kδ inhibitor under investigation for APDS...
Source: businessinsider.com